XML 40 R32.htm IDEA: XBRL DOCUMENT v3.19.3

Subsequent Events (Details) - Subsequent Event [Member] - USD ($)	1 Months Ended
	Oct. 15, 2019	Sep. 30, 2019	Oct. 03, 2019	Sep. 25, 2019
Subsequent Events (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)	50,000
Proceeds from Issuance of Common Stock	$ 158,603
Clinical Trial Agreement, Maximum Budgeted Costs			$ 57,800
Multi-Physician Medical Group [Member]
Subsequent Events (Details) [Line Items]
Clinical Trial Agreement, Maximum Budgeted Costs				$ 136,000
Common Stock [Member] | Max Health Medical International Limited [Member]
Subsequent Events (Details) [Line Items]
Shares Offer To Purchase (in Shares)		500,000

X

- Definition

The maximum budgeted costs related to clinical trial agreement.

+ References

No definition available.

+ Details

Name:	bmra_ClinicalTrialAgreementMaximumBudgetedCosts
Namespace Prefix:	bmra_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

Number of shares of common stock offered during the period for purchase.

+ References

No definition available.

+ Details

Name:	bmra_SharesOfferToPurchase
Namespace Prefix:	bmra_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	bmra_SubsequentEventsDetailsLineItems
Namespace Prefix:	bmra_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The cash inflow from the additional capital contribution to the entity.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585

+ Details

Name:	us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Number of new stock issued during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_MultiPhysicianMedicalGroupMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_EquityInterestIssuedOrIssuableByTypeAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=bmra_MaxHealthMedicalInternationalLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: